For the third year in a row VHIO´s Mouse Models of Cancer Therapies Group, led by Laura Soucek, has been awarded at the Annual Scientific Conference of the Vall d´Hebron Institute of Research (VHIR), now in its 9th edition.
Notably, Daniel Massó, a Graduate Student in Laura´s lab, has now made it a hat-trick for the group. Not only did he receive the prize for the best poster in 2013 for Inhibiting BTK Function as a Therapeutic Strategy in Pancreatic Cancer, this year he follows in the footsteps of Post-Doctoral Fellow of the same group, Marie-Eve Beaulieu, who received a prize for the best short talk at the same meeting a year ago.
In recognition of research on Targeting Myc in Breast Cancer Metastasis, Daniel was presented with a best poster prize alongside two other recipients in the same category — from among a total of 36 finalists.
“As we continue to evidence, inhibition of the Myc oncogene is proving a powerfully effective therapeutic strategy against several, if not all, tumor types”, comments Daniel Massó. “Our group has shown the efficacy of Myc inhibition by Omomyc expression in several previous studies. Omomyc, a Myc inhibitor designed by my mentor Laura Soucek, has proven efficacious across many primary tumors. For the first time we have now established this to be the case at preclinical level in mouse models of breast cancer metastasis”, he continues.
“These latest findings represent a promising forward step in tackling breast cancer metastasis – the main cause of death from this disease”, concludes Laura Soucek.
Keynoted this year by Edward Abrahams, President of the Personalized Medicine Coalition (PMC), the meeting drew an attendance of over 300 participants along with invited leading figures including Joan Comella, Director of VHIR, Pere Soley, Director General of the Catalan Institute of Health (ICS), and Vincenç Martínez Ibáñez, Managing Director of the Vall d´Hebron University Hospital (HUVH).
For more information please click here.
